Evidence map›Paper›PMID 24358170›Full record

ArticlePloS one2013

Evolution of exchangeable copper and relative exchangeable copper through the course of Wilson's disease in the Long Evans Cinnamon rat.

Françoise Schmitt, Guillaume Podevin, Joël Poupon, Jérôme Roux, Pierre Legras, Jean-Marc Trocello, France Woimant, Olivier Laprévote, Tuan Huy Nguyen, Souleiman El Balkhi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Monitoring of Copper in Wilson Disease.Diagnostics (Basel, Switzerland) · 2023
    Review
  5. Designing Clinical Trials in Wilson's Disease.Hepatology (Baltimore, Md.) · 2021
    Article
  6. Review
  7. Wilson's disease: Revisiting an old friend.World journal of hepatology · 2021
    Review
  8. Review
  9. Animal models of Wilson disease.Journal of neurochemistry · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Françoise SchmittINSERM UMR1064, Jean Monnet Hospital, Nantes, France ; HIFIH - Pediatric Hepatogastroenterology Team, University Hospital of Angers, Angers, France.
Guillaume PodevinHIFIH - Pediatric Hepatogastroenterology Team, University Hospital of Angers, Angers, France.
Joël PouponLaboratory of Biological Toxicology, Lariboisière Hospital, APHP, Paris, France.
Jérôme RouxSCAHU, Animal Facility, Medicine University of Angers, Angers, France.
Pierre LegrasSCAHU, Animal Facility, Medicine University of Angers, Angers, France.
Jean-Marc TrocelloDepartment of Neurology, Lariboisière Hospital, APHP, Paris, France ; Centre national de Maladie Rare Wilson, Lariboisière Hospital, APHP, Paris, France.
France WoimantDepartment of Neurology, Lariboisière Hospital, APHP, Paris, France ; Centre national de Maladie Rare Wilson, Lariboisière Hospital, APHP, Paris, France.
Olivier LaprévoteLaboratory of Biological Toxicology, Lariboisière Hospital, APHP, Paris, France ; Analytical and Experimental Toxicology (C-TAC), Faculty of Pharmacy, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
Tuan Huy NguyenINSERM UMR1064, Jean Monnet Hospital, Nantes, France.
Souleiman El BalkhiLaboratory of Biological Toxicology, Lariboisière Hospital, APHP, Paris, France ; Centre national de Maladie Rare Wilson, Lariboisière Hospital, APHP, Paris, France ; INSERM U1144, Variability of the Response to Psychotropic Drugs, Paris Descartes University, Sorbonne Paris Cité, Faculty of Pharmacy, Paris, France.
Université d'Angers · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FRSorbonne Paris Cité · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWilson's disease (WD) is an inherited disorder of copper metabolism leading to liver failure and/or neurological impairment. Its diagnosis often remains difficult even with genetic testing. Relative exchangeable copper (REC) has recently been described as a reliable serum diagnostic marker for WD. METHODOLOGY/PRINCIPAL

findingsThe aim of this study was to validate the use of REC in the Long Evans Cinnamon (LEC) rat, an animal model for WD, and to study its relevance under different conditions in comparison with conventional markers. Two groups of LEC rats and one group of Long-Evans (LE) rats were clinically and biologically monitored from 6 to 28 weeks of age. One group of LEC rats was given copper-free food. The other groups had normal food. Blood samples were collected each month and different serum markers for WD (namely ceruloplasmin oxidase activity, exchangeable copper (CuEXC), total serum copper and REC) and acute liver failure (serum transaminases and bilirubinemia) were tested. Every LEC rat under normal food developed acute liver failure (ALF), with 40% global mortality. Serum transaminases and bilirubinemia along with total serum copper and exchangeable copper levels increased with the onset of acute liver failure. A correlation was observed between CuEXC values and the severity of ALF. Cut-off values were different between young and adult rats and evolved because of age and/or liver failure. Only REC, with values >19%, was able to discriminate LEC groups from the LE control group at every time point in the study. REC sensitivity and specificity reached 100% in adults rats. CONCLUSIONS/SIGNIFICANCE: REC appears to be independent of demographic or clinical data in LEC rats. It is a very simple and reliable blood test for the diagnosis of copper toxicosis owing to a lack of ATP7B function. CuEXC can be used as an accurate biomarker of copper overload.

Indexed as

AnimalsCeruloplasminCopperDisease Models, AnimalDisease ProgressionFemaleHepatolenticular DegenerationLiverLiver FailureLiver Function TestsMaleRatsRats, Inbred LECCeruloplasminCopper

Identifiers

PMID24358170
PMCPMC3866119
OpenAlexW2018164612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.